Concepedia

Andrew L. MacKinnon

AL

13

Publications

2.3K

Citations

12

H-Index

2006

Active since

Affiliations

Calithera (United States)(Current)

Howard Hughes Medical Institute

University of California, San Francisco

University of California San Diego

National Institutes of Health

Andrew L. MacKinnon is an author at Calithera (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

2006–2022

13

Publications

13

Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer

Matt I. Gross, Susan D. Demo, Jennifer B. Dennison et al. · Molecular Cancer Therapeutics · 2014 · 1K citations

, , +18

Inhibition of arginase by CB-1158 blocks myeloid cell-mediated immune suppression in the tumor microenvironment

Susanne Steggerda, Mark K. Bennett, Jason Chen et al. · Journal for ImmunoTherapy of Cancer · 2017 · 416 citations · Full text

The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Sruthy Varghese, Snigdha Pramanik, Leila J. Williams et al. · Molecular Cancer Therapeutics · 2020 · 154 citations · Full text

Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11

Jing Li, Tanya Yakushi, Francesco Parlati et al. · Nature Chemical Biology · 2017 · 152 citations · Full text

, , +12

Photo-Leucine Incorporation Reveals the Target of a Cyclodepsipeptide Inhibitor of Cotranslational Translocation

Andrew L. MacKinnon, Jennifer L. Garrison, Ramanujan S. Hegde et al. · Journal of the American Chemical Society · 2007 · 136 citations · Full text

Rows per page

1–5 of 13